Financials

  • Market Capitalization 9.83 B
  • Employee 295
  • Founded 2016
  • CEO N/A
  • Website www.krystalbio.com
  • Headquarter Pennsylvania, United States
  • FIGI BBG00HDGRHH7
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
36.04
Fiyat/satışlar oranı
18.98

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
868
PCVX
Vaxcyte, Inc. - Common Stock
70.65 USD-1.02%-3.68%+17.67%+67.02%10.51 B USD
892
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
79.24 USD-0.68%+4.26%+1.73%+99.87%10.08 B USD
930
PTGX
Protagonist Therapeutics, Inc. - Common Stock
144.88 USD+0.80%+3.24%-3.36%+92.84%9.37 B USD
933
KYMR
Kymera Therapeutics, Inc. - Common Stock
112.08 USD-0.28%+0.95%-3.38%+89.64%9.32 B USD

Haberler